Patent · US Active

Method for bone formation by administering poly(lactic-co-glycolic acid) cross-linked alendronate

US9889225B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2015
Grant dateFeb 13, 2018
Priority date—
Expiry dateFeb 5, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2982
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method for bone regeneration which comprises administering a short term release composition into a bone area of a subject in need thereof, wherein the composition comprises a poly(lactic-co-glycolic acid) cross-linked alendronate (PLGA-ALN), wherein the composition releases the alendronate into the bone area, wherein the bone tissue of the bone area is exposed in situ to a therapeutically effective amount of the alendronate over 9 days.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.